EVICR.net is a platform for multinational clinical research in Ophthalmology in Europe and a structure to support multinational Investigator-Initiated Research (IIR). IIR are studies instigated by academic researchers.
If you are an Investigator and you have an idea for a multinational clinical study, EVICR.net helps you to develop your idea in a clinical research study in ophthalmology.
Consult the EVICR.net Investigator Initiated Research (IIR) leaflet for further information.
Ongoing Investigator Initiated Research
1. ClinicalTrials.gov nº NCT06709339
MONDEGO – A phase IV, multicentre, open-label, single-arm study to investigate the efficacy, safety and durability of faricimab (RO6867461) in caucasian patients with polypoidal choroidal vasculopathy”
Coordinating Investigator: Rufino Silva, Coimbra, Portugal (CS82)
Participating Centres (30): Italy, Portugal, Spain and UK.
Sponsor: AIBILI, as EVICR.net Coordinating Centre
Financial Support: Roche
2. ClinicalTrials.gov nº NCT05698316
INTERCEPT-AMD – A collaborative resource of Heidelberg multimodal imaging of Intermediate AMD with and without early atrophy to study prediction of disease progression
Coordinating Investigator: Sobha Sivaprasad, London, UK (CS10)
Participating Centres (20): Denmark, France, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom
Sponsor: AIBILI, as EVICR.net Coordinating Centre
Financial Support: Boehringer Ingelheim International GmbH
3. ClinicalTrials.gov ID: NCT04636307
CHART – Characterization of Retinal Disease Progression in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures
Coordinating Investigator: J. Cunha-Vaz (CS 1)
Characterisation of Biomarkers of Diabetic Retinal Disease Progression in eyes with NPDR using non-invasive procedures.
Participating Centres (5): Portugal, Italy, France
IIR Grant: Bayer
4. ClinicalTrials.gov nº NCT04281186
RECOGNISED –Retinal and Cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia
Coordinating Investigator: R. Simó, Barcelona, Spain (CS74)
Participating Centres (10): Denmark, Italy, Netherlands, Portugal, Spain and UK
Sponsor: Fundació Hospital Universitari Vall D’Hebron, VHIR, represented by Prof. Rafael Simó.
Financial Support: Horizon 2020 – Project nº 847749
5. ClinicalTrials.gov nº NCT03349801
MACUSTAR – Intermediate AMD: Development of novel clinical endpoints for clinical trials in patients with a regulatory and patient access intention
Coordinating Investigator: Frank Holz, Bonn, Germany (CS15)
Participating Centres (20): Denmark, France, Germany, Italy, Netherlands, Portugal, United Kingdom
Sponsor: University Hospital Bonn
Financial Support: IMI2 and EFPIA – Project nº 116076